DE3862637D1 - Tetra- und penta-peptide mit der sequenz lysyl-arginyl-aspartyl, und ihre verwendung als antithrombotika. - Google Patents

Tetra- und penta-peptide mit der sequenz lysyl-arginyl-aspartyl, und ihre verwendung als antithrombotika.

Info

Publication number
DE3862637D1
DE3862637D1 DE8888402713T DE3862637T DE3862637D1 DE 3862637 D1 DE3862637 D1 DE 3862637D1 DE 8888402713 T DE8888402713 T DE 8888402713T DE 3862637 T DE3862637 T DE 3862637T DE 3862637 D1 DE3862637 D1 DE 3862637D1
Authority
DE
Germany
Prior art keywords
antithrombotics
arginyl
lysyl
aspartyl
tetra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888402713T
Other languages
English (en)
Inventor
Pierre Jolles
Anne-Marie Fiat
Claudine Soria
Sylviane Levy-Toledano
Indian Institute Of Raha
Elizabeth Mazoyer
Ludovic Drouet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
IVS Institut des Vaisseaux et du Sang
Original Assignee
Centre National de la Recherche Scientifique CNRS
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, IVS Institut des Vaisseaux et du Sang filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE3862637D1 publication Critical patent/DE3862637D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8888402713T 1987-10-30 1988-10-27 Tetra- und penta-peptide mit der sequenz lysyl-arginyl-aspartyl, und ihre verwendung als antithrombotika. Expired - Lifetime DE3862637D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8715061A FR2622587B1 (fr) 1987-10-30 1987-10-30 Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique

Publications (1)

Publication Number Publication Date
DE3862637D1 true DE3862637D1 (de) 1991-06-06

Family

ID=9356340

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888402713T Expired - Lifetime DE3862637D1 (de) 1987-10-30 1988-10-27 Tetra- und penta-peptide mit der sequenz lysyl-arginyl-aspartyl, und ihre verwendung als antithrombotika.

Country Status (6)

Country Link
US (1) US4943562A (de)
EP (1) EP0314576B1 (de)
JP (1) JPH01149799A (de)
AT (1) ATE63126T1 (de)
DE (1) DE3862637D1 (de)
FR (1) FR2622587B1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394326B1 (de) * 1987-12-10 1996-07-31 La Jolla Cancer Research Foundation Verfahren zur herstellung von conformationnell stabilisierten zelladhäsionspeptiden
US5827821A (en) * 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
US5686566A (en) * 1989-06-16 1997-11-11 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5807828A (en) * 1989-06-16 1998-09-15 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
DK0527798T3 (da) * 1990-04-06 1997-12-15 Jolla Cancer Res Found Fremgangsmåde og sammensætning til behandling af thrombose
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
US5705486A (en) * 1996-03-14 1998-01-06 Yoshihide Hagiwara Isolation of novel peptides from green barley leaf extract and use same to inhibit human platelet aggregation
US6210904B1 (en) * 1997-10-14 2001-04-03 Merck & Co., Inc. Anticoagulant test
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US8209514B2 (en) * 2008-02-04 2012-06-26 Qnx Software Systems Limited Media processing system having resource partitioning

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
US4190647A (en) * 1979-01-26 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptides and methods
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US4305852A (en) * 1980-10-20 1981-12-15 American Home Products Corporation Polypeptide compositions
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors

Also Published As

Publication number Publication date
EP0314576B1 (de) 1991-05-02
FR2622587B1 (fr) 1990-12-21
FR2622587A1 (fr) 1989-05-05
EP0314576A1 (de) 1989-05-03
ATE63126T1 (de) 1991-05-15
US4943562A (en) 1990-07-24
JPH01149799A (ja) 1989-06-12

Similar Documents

Publication Publication Date Title
DE3862637D1 (de) Tetra- und penta-peptide mit der sequenz lysyl-arginyl-aspartyl, und ihre verwendung als antithrombotika.
ATE89315T1 (de) Faktor viii-analog, verfahren zu dessen herstellung und dieses enthaltende zusammensetzung.
DE59209810D1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
ES2052545T3 (es) (n-piperidinil)-metil- y (n-piperazinil)metilazoles sustituidos con arilo que tienen propiedades antipsicoticas.
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
GR3035067T3 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins.
DE10075019I1 (de) Neue Proteine mit TNF-Hemmender wirkung und ihre Herstellung.
DE69029406D1 (en) Polypeptid
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
Li Proposed system of terminology for preparations of adrenocorticotropic hormone
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
DE59307354D1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
KR100295606B1 (de)
ATE126237T1 (de) Lymphocyteninhibierung durch hla-peptide.
ATE198901T1 (de) Farbstoffreste aufweisende organopolysiloxane
GR852541B (de)
DK414182A (da) Bis-thymosin-alfa1-forbindelser
DE69606321D1 (de) Stabilisiertes sonnenschutzmittel
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
DE59410221D1 (de) Rekombinante chladosporium herbarum allergene
KR850007802A (ko) 펩타이드의 제조방법
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
ATE27822T1 (de) Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.
KR970701732A (ko) 펩신 방출을 억제하기 위한 펩티드(Peptides Inhibiting the Release of Pepsin)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee